Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women

Marjanka K. Schmidt*, Alexandra J. van den Broek, Rob A. E. M. Tollenaar, Vincent T. H. B. M. Smit, Pieter J. Westenend, Mariel Brinkhuis, Wolter J. W. Oosterhuis, Jelle Wesseling, Maryska L. Janssen-Heijnen, Jan J. Jobsen, Agnes Jager, Adri C. Voogd, Flora E. van Leeuwen, Laura J. van 't Veer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number329
Number of pages10
JournalJournal of the National Cancer Institute
Volume109
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • INHERITED MUTATIONS
  • BRCA1
  • POPULATION
  • RISK
  • CHEMOTHERAPY
  • PROGNOSIS
  • IMPUTATION
  • FAMILIES
  • TRENDS
  • GENES

Cite this

Schmidt, M. K., van den Broek, A. J., Tollenaar, R. A. E. M., Smit, V. T. H. B. M., Westenend, P. J., Brinkhuis, M., Oosterhuis, W. J. W., Wesseling, J., Janssen-Heijnen, M. L., Jobsen, J. J., Jager, A., Voogd, A. C., van Leeuwen, F. E., & van 't Veer, L. J. (2017). Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women. Journal of the National Cancer Institute, 109(8), [329]. https://doi.org/10.1093/jnci/djw329